3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Fibrolamellar hepatocellular carcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Paclitaxel
12
Carboplatin
12
Bevacizumab
11
liposomal doxorubicin
8
Specimen Handling
8
olaparib
7
Magnetic Resonance Spectroscopy
7
Topotecan
4
Gemcitabine
4
Biopsy
4
pembrolizumab
3
mirvetuximab soravtansine
3
Taxes
3
Doxorubicin
3
sarilumab
2
niraparib
2
cemiplimab
2
cediranib
2
Immunoglobulin G
2
Disulfides
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
tocilizumab
1
sotorasib
1
peposertib
1
pelcitoclax
1
palbociclib
1
nilotinib
1
neratinib
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
poly ICLC
×
30 days
×
Clear all
No trials found.